MINUTES OF PROCEEDINGS OTTAWA, Wednesday, October 2, 2024 (115) [English] The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:21 p.m., in room B45, Senate of Canada Building, the chair, the Honourable Ratna Omidvar, presiding. Members of the committee present: The Honourable Senators Bernard, Brazeau, Burey, Dasko, Mégie, Moodie, Omidvar, Osler, Pate, Petitclerc and Seidman (11). Other senators present: The Honourable Senators LaBoucane-Benson, McBean, Miville-Dechêne and Senior (4).

Participating in the meeting: Laura Blackmore and Mayra Perez-Leclerc, analysts, Library of Parliament. Pursuant to the order of reference adopted by the Senate on Tuesday, June 18, 2024, the committee continued its study of Bill C-64,

An Act respecting pharmacare. WITNESSES: Innovative Medicines Canada: Bettina Hamelin, President; Declan Hamill, Vice-President, Policy, Regulatory and Legal Affairs. Canadian Generic Pharmaceutical Association: Jim Keon, President; Jody Cox, Vice-President, Federal and International Affairs. Canadian Life and Health Insurance Association: Stephen Frank, President and Chief Executive Officer. Canadian Chamber of Commerce: Liam MacDonald, Director, Policy and Government Relations; Kathy Megyery, Senior Vice-President and General Manager, Quebec.

Canadian Labour Congress: Siobhán Vipond, Executive Vice-President; Elizabeth Kwan, Senior Researcher. Bettina Hamelin and Jim Keon each made a statement and, together with Declan Hamill and Jody Cox, answered questions. At 5:18 p.m., the committee suspended. At 5:22 p.m., the committee resumed. Stephen Frank, Kathy Megyery and Siobhán Vipond each made a statement and answered questions. At 6:13 p.m., the committee adjourned to the call of the chair. ATTEST: Emily Barrette Clerk of the Committee